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on the mimicry of the physical and bio-
chemical cues of extracellular matrices 
(ECMs) that are encountered in vivo and 
regulate cell behavior, including phe-
nomena like adhesion, migration, pro-
liferation, and differentiation. Like other 
proteins that constitute physiological 
ECMs, vitronectin (VN) has a plethora of 
functions in tissue repair and homeostatic 
processes, including remodeling, and has 
been recently indicated as a biological 
“superglue.”[1] This 75 kDa adhesive gly-
coprotein is a substantial component 
of plasma (≈300 µg mL−1)[2] and is also 
found in the extracellular space of dif-
ferent tissues. Contrary to other ECM 
proteins with structural functions, like 
collagens, fibronectin (FN) or laminin, 
VN is a “matricellular” protein: its func-
tions depend on the interaction with other 
species, including matrix proteins, cell-
surface receptors, or other molecules such 
as cytokines.[3] It exhibits a high degree 
of conformational flexibility, and each 
conformation supports distinct biological 
activity.[4] Ultimately, through its direct or 
indirect interactions with several extracel-
lular species, VN is involved in various physiological and patho-
logical processes, which include response to tissue trauma, 
angiogenesis, and cancer progression.[5] The protein also con-
tains an arginine–glycine–aspartic acid (RGD) motif which 
mediates binding to different members of the integrin family 
(αvβ1, αvβ3, αvβ5, αvβ6, αvβ8, and αIIbβ3).[6] Engagement of VN 
with cell surface receptors contributes to cell adhesion and inte-
grin-mediated signal transduction. For example, binding of VN 
to its main integrin receptor (αvβ3) was reported to be involved 
in the initiation of the assembly of FN fibrils by cells.[7] The role 
of adsorbed VN during initial cell–biomaterials interactions 
has also been addressed in different studies,[8] revealing that 
the protein undergoes dynamic remodeling at the cell–material 
interface.[9] Moreover VN, together with FN, is the main adhe-
sive component of sera used in cell culture.[10]
Fibronectin, a higher-molecular-weight glycoprotein found 
in soluble form in blood and in an insoluble form in connec-
tive tissues,[11] is, on the other hand, an abundant structural 
component of the ECM. Its importance in the mediation of 
cell adhesion was early recognized.[12] It is a dimer consisting 
of two subunits of ≈220 kDa, each containing three types of 
repeating units that mediate interactions with ECM proteins, 
several members of the integrin family, and other molecules. 
Surface functionalization strategies of synthetic materials for regenerative 
medicine applications comprise the development of microenvironments that 
recapitulate the physical and biochemical cues of physiological extracellular 
matrices. In this context, material-driven fibronectin (FN) nanonetworks 
obtained from the adsorption of the protein on poly(ethyl acrylate) provide a 
robust system to control cell behavior, particularly to enhance differentiation. 
This study aims at augmenting the complexity of these fibrillar matrices by 
introducing vitronectin, a lower-molecular-weight multifunctional glycoprotein 
and main adhesive component of serum. A cooperative effect during co-
adsorption of the proteins is observed, as the addition of vitronectin leads to 
increased fibronectin adsorption, improved fibril formation, and enhanced 
vitronectin exposure. The mobility of the protein at the material interface 
increases, and this, in turn, facilitates the reorganization of the adsorbed  
FN by cells. Furthermore, the interplay between interface mobility and engage-
ment of vitronectin receptors controls the level of cell fusion and the degree of 
cell differentiation. Ultimately, this work reveals that substrate-induced protein 
interfaces resulting from the cooperative adsorption of fibronectin and vitron-
ectin fine-tune cell behavior, as vitronectin micromanages the local properties 
of the microenvironment and consequently short-term cell response to the 
protein interface and higher order cellular functions such as differentiation.
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Tissue Engineering
1. Introduction
Engineering biologically active microenvironments to support 
tissue regeneration demands careful consideration of the pro-
tein interface that governs the interaction between synthetic 
materials and adhering cells. The design of this interface relies 
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As a result, FN plays a crucial role in the regulation of cell 
survival and phenotype expression in vivo[13] and in vitro when 
directly adsorbed on a variety of substrates or as a component 
of serum.[14] Moreover, the engagement of FN with integrins 
promotes a force-mediated reorganization of the molecule, 
which results in the formation of matrix fibrils through FN–
FN lateral association (fibrillogenesis); the occurrence and the 
intensity of this phenomenon for FN adsorbed onto synthetic 
surfaces are considered a key factor in the biocompatibility of a 
material and in determining cell behavior.[15]
Surface chemistry has been revealed, together with other 
surface properties, to be able to modulate the adsorption of dif-
ferent biologically relevant molecules, including VN and FN,[16] 
regulating eventually the fate of the cells which subsequently 
adhere to that biointerface.[14,17] For example, we have previously 
shown that specific surface chemistries, e.g., poly(ethyl acrylate) 
(PEA), trigger the cell-free assembly of FN into physiological-like 
matrices.[18] These FN fibrils have enhanced biological activity 
due to the simultaneous exposure of the central cell-binding 
domain (FNIII9–10) that promotes α5β1 engagement and of a pro-
miscuous growth factor (GF)-binding domain (FNIII12–14) that 
allows for integrin-GF synergistic signaling.[19] This work further 
explores the effect of VN on material-driven FN fibrillogenesis, by 
co-adsorbing both proteins onto PEA surfaces (Figure 1A).[20] The 
introduction of this multifunctional adhesive glycoprotein known 
for its matricellular role in vivo will augment the complexity of 
the artificial fibrillar microenvironment. Moreover, it will shed 
light on the interaction between these two fundamental compo-
nents of interstitial ECM and key adhesive factors of serum in 
a setting that mimics a physiological fibrillar microenvironment.
2. Results
2.1. Protein Adsorption
In this study, the role of VN in the modulation of the adsorp-
tion and material-driven fibrillogenesis of FN on PEA was 
characterized, following previous indications that VN confers 
higher mobility to the protein matrix formed at the material 
interface and adds complexity to its biological activity.[20] As 
previously reported, the presence of VN enhanced FN adsorp-
tion.[20] Figure 1B shows the amount of FN on PEA after 1 h 
adsorption under noncompetitive or competitive conditions: 
FN was absorbed either from single protein solutions of con-
centrations 3, 5, 7, and 10 µg mL−1 (designated as FN3, FN5, 
FN7, and FN10) or from 10 µg mL−1 FN/VN mixtures in dif-
ferent weight ratios (30%/70%, 50%/50%, and 70%/30%, des-
ignated as FN3/VN7, FN5/VN5, and FN7/VN3). As expected, 
the surface density of adsorbed FN increased with the concen-
tration of FN in the coating solution, regardless of the pres-
ence, or not, of VN (Figure 1B). Most interestingly, a higher 
amount of FN was adsorbed onto PEA surfaces when the pro-
teins were competitively adsorbed from mixtures containing as 
much as 50% VN. Beside the amount of adsorbed FN, the pro-
tein interface was further characterized in terms of the avail-
ability of cell-binding domains on both adsorbed FN and VN 
(indicated in Figure 1A). The exposure of the central binding 
domain on FN (containing the RGD sequence) was measured 
via binding of the monoclonal antibody HFN7.1, which is tar-
geted against the flexible linker between the ninth and tenth 
type III repeats of the protein, and is a receptor-mimetic probe 
for integrin binding and cell adhesion.[21] Minimal differences 
were found in the availability of the cell-binding domain on 
the adsorbed protein independently of the concentration of 
the protein solution (only 5 and 10 µg mL−1 FN solutions were 
used) or of the presence of VN (FN5/VN5) (Figure 1C); when 
these results were normalized by the amount of adsorbed FN, 
the exposure of the RGD domain per protein diminished with 
increasing FN concentration or when VN was added in the 
coating solution.
Similar to FN, the amount of VN adsorbed onto the sur-
face increased with the concentration of the protein in the 
coating solution (Figure 1D); in this case, though, adsorption 
from FN/VN mixtures led to a decrease in the surface density 
of adsorbed VN. Furthermore, the availability of VN for cell 
binding was assessed using a monoclonal antibody (mab1945) 
known to inhibit cell adhesion to VN when added to VN-coated 
substrates.[22] On pure VN coatings, the availability of the pro-
tein increased slightly with VN concentration (Figure 1E; VN5 
and VN10, indicating adsorption from solution of concentra-
tion 5 and 10 µg mL−1, respectively). Surprisingly, co-adsorption 
of the protein with FN (FN5/VN5) led to an increase of VN 
exposure (higher even than VN10), despite the lower adsorbed 
amount (Figure 1E); normalized availability values showed that 
the exposure of the RGD domain per protein diminished with 
increasing VN concentration, while it increased when FN was 
also present.
Phase imaging in tapping mode AFM was then used to 
analyze the distribution and micro- and nanostructures of the 
adsorbed protein (Figure 2); adsorption of FN on PEA promoted 
organization of the protein into fibrillar structures resembling 
FN organization in vivo or in vitro by cells (Figure 2A, FN5).[18] 
On the other hand, VN was adsorbed in the form of small 
aggregates (Figure 2A, VN5). When both proteins were co-
adsorbed, a protein network with thicker fibrils and a higher 
degree of interconnectivity was obtained (Figure 2A, FN5/VN5), 
in agreement with previous results.[20] This observation was 
confirmed by quantifying the level of complexity and connec-
tivity of the protein matrix: addition of VN during the adsorp-
tion increased the fractal dimension and the ratio of junctions 
to end points (Figure 2A,B); moreover, the length of the matrix 
branches increased significantly from ≈25 to ≈43 nm (cor-
respondingly, there was an increase of the maximum branch 
length from ≈130 to ≈190 nm) (Figure 2C,D). Further insight 
into the adsorption of the two proteins was gained by consecu-
tively adsorbing VN (or FN) on a previously adsorbed FN (or 
VN) layer. When VN was adsorbed onto an FN-coated polymer 
surface, a protein network similar to the one obtained from 
a pure FN solution was observed, the only difference being a 
slight thickening of the matrix fibrils (Figure 2A, FN5+VN5); 
both matrices had indeed similar fractal dimensions, junc-
tions to end points ratio, and branch lengths. On the other 
hand, when FN was adsorbed onto VN-coated PEA, large pro-
tein fibrils were observed that included most of the previously 
adsorbed VN aggregates (Figure 2A, VN5+FN5). Quantification 
of the images confirmed that precoating the surface with VN, 
although it diminished the connectivity of the protein layer, 
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brought about an increase of the branch length to similar levels 
as the co-adsorption.
To elucidate the role of both proteins within this protein 
matrix, VN molecules available for cell binding were tagged 
with a monoclonal antibody (mab1945) and then with a sec-
ondary antibody bound to a 15 nm gold nanoparticle (Figure 3). 
VN molecules, indicated by the height signal corresponding to 
the presence of nanoparticles, were identified by thresholding; 
superposition of the phase image of the protein network with 
the thresholded height magnitude identified the branch points of 
the matrix as the preferred localization for the exposed VN mole-
cules (Figure 3C), which have an average spacing of ≈350 nm.
Adv. Biosys. 2017, 1, 1700047
Figure 1. Adsorption of fibronectin and vitronectin on PEA under non-competitive and competitive conditions. A) Schematic representation of the 
adsorption of FN and VN from solution onto PEA surfaces and models for the III7–10 domains of FN (FNIII7–10) and for the entire VN molecule, 
highlighting the RGD sequence on each protein in yellow, along with the binding sites for HFN7.1 and mab1945 antibodies; models are adapted from 
Protein Data Bank (PBD) ID: 1FNF[23] for FNIII7–10 and PBD ID: 1SSU[24] for VN. B) Surface density of adsorbed FN on PEA from single protein solu-
tions (FN3 (3 µg mL−1), FN5 (5 µg mL−1), FN7 (7 µg mL−1), and FN10 (10 µg mL−1)) or mixtures with VN (FN3/VN7 (FN = 3 µg mL−1, VN = 7 µg mL−1), 
FN5/VN5 (FN = 5 µg mL−1, VN = 5 µg mL−1), FN7/VN3 (FN = 7 µg mL−1, VN = 3 µg mL−1)). C) Availability of the central integrin-binding domain of 
FN as measured by binding of HFN7.1 monoclonal antibody on single protein and mixed proteins coatings; in the second graph, the availability is nor-
malized by the amount of adsorbed FN. D) Surface density of adsorbed VN on PEA from single protein solutions (VN3 (3 µg mL−1), VN5 (5 µg mL−1), 
VN7 (7 µg mL−1), and VN10 (10 µg mL−1)) or mixtures with FN. E) Availability of the integrin-binding domain of VN after adsorption on PEA as 
measured by binding of mab1945 monoclonal antibody; in the second graph, the availability is normalized by the amount of adsorbed VN. Statistically 
significant differences are indicated with *p < 0.05 and **p < 0.1.
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2.2. Cell-Mediated FN Reorganization
Cell-mediated remodeling of the FN adsorbed on the sur-
face was evaluated via immunostaining using C2C12 cells in 
serum-free conditions (Figure 4). When seeded on surfaces 
coated with 5 µg mL−1 of FN, most cells adopted a rounded 
morphology after 3 h and a brighter area in the stained 
FN layer appeared around the cells (Figure 4, third column). 
Adv. Biosys. 2017, 1, 1700047
Figure 3. AFM imaging of immunogold labelled VN molecules on FN/VN-coated PEA. A) Height signal in tapping mode AFM after co-adsorption of 
FN (5 µg mL−1) and VN (5 µg mL−1) on PEA and immunogold staining: a secondary antibody bound to a 15 nm gold nanoparticle was used to identify 
available VN molecules as brighter peaks in the image. B) Corresponding phase signal. C) Magnification of the phase signal: the image is merged 
with the thresholded height signal (in blue) to identify the location of the gold nanoparticles. The primary antibody mab1945 recognizes VN molecules 
available for cell binding and the secondary antibody is tagged with a 15 nm gold nanoparticle. Scale bar: 200 nm.
Figure 2. Structure and distribution of FN and VN adsorbed, co-adsorbed, or consecutively adsorbed on PEA. A) Phase signal in tapping mode AFM: 
FN5, adsorption of FN (5 µg mL−1); VN5, adsorption of VN (5 µg mL−1); FN5/VN5, co-adsorption of FN (5 µg mL−1), and VN (5 µg mL−1); FN5+VN5, 
consecutive adsorption of FN and VN; VN5+FN5, consecutive adsorption of VN and FN; fractal dimension of the adsorbed protein layers. B) Ratio 
between junctions and end points of the protein matrix. C) Average length of the branches of the protein network. D) Maximum length of the branches. 
All differences are statistically significant (p < 0.05), with the exception of the ones indicated with ∼. Scale bar: 200 nm.
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This shrunk cell morphology (resulting in a small cell size, 
Figure 4E) and the surrounding imprint on the protein inter-
face indicated impaired early cell adhesion; this is attributed 
to the restricted nanoscale mobility of FN molecules as a 
consequence of high strength of interaction between FN and 
the underlying polymer (PEA), which leads to proteolysis.[25] 
Adv. Biosys. 2017, 1, 1700047
Figure 4. Cell-mediated FN reorganization after 3 h incubation on FN/VN-coated surfaces in serum-free conditions. A) Actin cytoskeleton (green) and nuclei 
(blue). B) Corresponding cell-mediated FN reorganization. C) Magnification of FN reorganization around single cells; insets indicate examples of FN reor-
ganization by cells. D) Corresponding actin cytoskeleton (green) and nuclei (blue). E) Cell size. Mab1945 is used to block VN availability (second column); 
controls include reorganization of coatings of sole FN in serum-free conditions (third column), with 5 µg mL−1 of VN in the culture medium (fourth column), 
and in the presence of 2.5% serum (fifth column). All differences are statistically significant (p < 0.05), with the exception of the ones indicated with ∼.
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A certain degree of recovery from this effect could be observed 
when cells were seeded onto substrates coated with a mix-
ture of FN and VN; many cells still left an imprint on the FN 
layer surrounding them, but indications of FN reorganization 
by cells (Figure 4C, first column) and of a more spread cell 
morphology (and bigger cell size, Figure 4E) were found. This 
positive influence of VN integration within the protein matrix 
on early cell response was maintained even when availability 
of VN for integrin binding was blocked using mab1945 anti-
body (Figure 4C (second column),E). As controls, cells seeded 
in serum-containing culture medium were observed to spread 
(Figure 4E) and reorganize FN (Figure 4, fifth column); on 
the other hand, addition of VN to the medium did not trigger 
the same cell response than adding serum (Figure 4 (fourth 
column), E).
2.3. Cell Differentiation
The effect of VN was further investigated via differentiation 
assays. C2C12 cells were cultured on substrates coated with FN, 
VN, or mixtures of the two, and the level of myogenic differen-
tiation measured via staining of sarcomeric myosin (Figure 5A). 
A nonmonotonic dependence of the degree of differentiation, 
characterized as the percentage of sarcomeric-myosin positive 
cells, was observed as the content of VN increased (Figure 5B); 
highest differentiation levels were found on pure protein coat-
ings (FN10 and VN10), while a minimum was reached for a 
50/50 protein ratio in the coating solution. Moreover, the pres-
ence of VN triggered higher levels of cell fusion, with the for-
mation of bigger multinucleated myotubes compared to sole 
FN; this was measured by the perimeter-to-area ratio of the 
myotubes, which was shown to monotonically decrease with the 
content of VN, as thicker myotubes were formed (Figure 5C). 
Results for the full series of pure protein coatings are reported 
in Figure S1 (Supporting Information).
Observation of cell differentiation over time revealed that this 
phenomenon is likely related to an earlier onset of cell fusion 
in the presence of VN (Figure 6A). Indeed, even if cell prolif-
eration followed a similar trend independently of the protein 
coating on the surface (Figure 6B), the presence of VN favored 
the organization of cells into clusters at early time points, as 
measured by the lower confluence degree with respect to pure 
FN coatings (Figure 6C).
Further insight into the role of the protein interface in the 
differentiation process was obtained by blocking the availability 
of the RGD sequence on either FN or VN using the monoclonal 
antibodies HFN7.1 and mab1945, respectively (Figure 7A). 
Inhibiting integrin binding to the RGD motif drastically low-
ered the differentiation levels on pure protein coatings (from 
≈55% to ≈30%; Figure 7B). This was accompanied by decreased 
levels of cell fusion (higher perimeter-to-area ratios) and 
reduced cell density; the effect was more pronounced on VN-
coated substrates (Figure 7C,D). On substrates coated by a 
50/50 mixture of both proteins, only blocking the availability of 
VN led to a significant decrease of differentiation (Figure 7B); 
the levels were nevertheless only slightly affected. Impaired cell 
binding to VN resulted in hindered cell fusion and lower dif-
ferentiation levels compared to blocking binding to FN through 
its RGD sequence.
3. Discussion
Various studies have sought to combine the customization of 
material bulk and surface properties with relevant proteins 
Adv. Biosys. 2017, 1, 1700047
Figure 5. Myogenic differentiation of C2C12 cells on PEA surfaces coated with mixtures of FN and VN in different ratios. A) Sarcomeric myosin-positive 
cells (red) and nuclei (blue) after 4 d of culture. B) Differentiation levels measured as the percentage of sarcomeric myosin-positive cells. C) Perimeter-to-
area ratio of the myotubes as an indicator of cell fusion. Dotted lines are guides for the eye. Statistically significant differences are indicated with *p < 0.05.
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to prompt the production of microenvironments that con-
trol cell response, with the ultimate objective of targeting cell 
differentiation, e.g., in mesenchymal stem cells, to defined 
lineages.[14a,c,26] This work builds on this concept by engineering 
artificial fibrillar microenvironments that exploit the interac-
tion between one of the main structural ECM components, FN, 
and a particular surface chemistry, PEA. We have previously 
shown that this acrylate is able to trigger the cell-free organi-
zation of FN molecules into physiological-like nanofibrils upon 
adsorption of the protein onto the material surface, regardless 
of surface topography;[18,27] the resulting biointerface promotes 
cell adhesion and differentiation in vitro and supports bone 
regeneration in vivo.[19,28] We have also observed that other 
proteins or protein fragments affect this material-driven FN 
assembly,[20,28] and we have identified VN as a promising can-
didate to alter FN organization at the cell–material interface.[20] 
VN is in fact a low-molecular-weight matricellular component 
of the ECM and main adhesive component of serum, known 
to organize and micromanage the local hydrogel milieu in 
vivo through interactions with several other ECM molecules;[1] 
indeed, it forms multiprotein complexes with a repertoire of 
biologically active species, modulating their biological func-
tions. Here, we elucidate its role and interactions in an artificial 
fibrillar matrix which mimics a physiological ECM (Figures 1A 
and 8A).
The protein/material interface was characterized by observing 
the amount, conformation, and organization of the adsorbed 
proteins following co-adsorption of structural FN and 
Adv. Biosys. 2017, 1, 1700047
Figure 6. C2C12 cells differentiation over time (time points 3 h, 24 h, 48 h, 72 h, and 96 h). A) Actin cytoskeleton (green) and nuclei (blue) on single 
protein coatings (10 µg mL−1 of FN or VN) and mixed FN5/VN5 coating. B) Cell density over time. C) Cell confluence over time. Statistically significant 
differences are indicated with *p < 0.05.
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matricellular VN in different ratios. Results interestingly reveal 
that addition of up to 50% of VN to the coating solution leads 
to cooperative effects during the adsorption process of both 
proteins, rather than to the competitive effects that are usu-
ally observed when proteins are absorbed from mixtures.[16b,29] 
Indeed, FN is adsorbed in higher amounts when co-adsorbed 
with VN compared to adsorption of the single protein 
(Figure 1B), the availability of VN is enhanced despite its lower 
surface density (Figure 1D,E), and ultimately fibril formation 
and interconnection is improved (Figure 2). Several phenomena 
likely contribute to determine this cooperative effect, as a result 
of the interactions between the two adsorbing species while the 
structural component, FN, is undergoing a material-induced 
conformation change and subsequent self-assembly. On the 
one hand, VN does not seem to alter the biological properties 
of the adsorbed FN; after co-adsorption, the protein still forms 
biologically functional fibrils (Figure 1C). Moreover, consecu-
tive adsorption of VN on top of a preadsorbed FN layer leads 
Adv. Biosys. 2017, 1, 1700047
Figure 7. Myogenic differentiation of C2C12 cells on FN/VN-coated PEA surfaces after blocking the RGD motif on FN or VN using monoclonal anti-
bodies (HFN7.1 for FN, mab1945 for VN). A) Sarcomeric myosin-positive cells (red) and nuclei (blue) after 4 d of culture. B) Differentiation levels 
measured as the percentage of sarcomeric myosin-positive cells. C) Perimeter-to-area ratio of the myotubes as an indicator of cell fusion. D) Cell density. 
Controls include single protein coatings. Statistically significant differences are indicated with *p < 0.05.
Figure 8. VN as a micromanager of the fibrillar FN microenvironment and of cell response. A) Matricellular VN, a smaller molecular weight protein than 
structural FN, is integrated in the protein network and acts a plasticizer of the FN fibrils, increasing the mobility of the protein interface; it also gains 
exposure for cell binding via VN receptors (αv integrins). Altered physical and biological properties of the microenvironment fine-tune cell response: cell 
adhesion, remodeling of the adsorbed FN, and ultimately cell differentiation. B) Cell differentiation and cell fusion (indicated by the perimeter-to-area 
ratio) as a function of the ratio of adsorbed VN (XVN) or FN (XFN) at the protein interface; dotted lines are guides for the eye.
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to protein networks with similar fractal properties (Figure 2A). 
On the other hand, VN affects the physical properties of the 
microenvironment; the thicker and longer fibrils are likely 
the result of the indirect interaction of VN molecules with 
the adsorbing FN. VN, integrated in the protein network but 
without any direct binding domain with FN,[1,5b,30] facilitates 
the mobility of FN at the interface with the material surface, 
contributing to faster dynamics in the formation of the protein 
matrix.[20] This is in accordance with previous results that show 
that a higher interfacial mobility is correlated with faster adsorp-
tion dynamics and FN organization into nanonetworks;[25b,31] 
here the higher interfacial mobility is obtained due to the pres-
ence of VN, a protein with lower molecular weight which plays 
the role of plasticizer of larger FN molecules; in Bathawab 
et al.[25b] it is translated from an increased polymer surface 
mobility. Other studies have also reported higher FN adsorption 
on surfaces with increased chain flexibility.[32] Furthermore, VN 
acts as a nucleation point for the adsorption of FN molecules, 
as exemplified by adsorbing FN onto preadsorbed clusters of 
VN molecules; the resulting large protein fibrils have similar 
lengths to the ones achieved through co-adsorption and include 
most of the VN aggregates (Figure 2). Thus, we speculate that 
VN acts similarly during the initial stages of adsorption from a 
mixture of the proteins, which are known to be dominated by 
the species of lower molecular weight.[33] As part of the ensuing 
protein network, VN molecules appear to gain higher exposure 
when adsorbed onto PEA in the presence of FN compared to the 
aggregates formed upon adsorption from a pure VN solution 
(Figure 1E); interestingly, available molecules are preferentially 
located in the branch points of the matrix (Figure 3), pointing 
again at their activity as nucleation points. This enhanced 
and organized availability cannot be ascribed to a change in 
the amount of adsorbed VN (VN surface density diminishes 
during co-adsorption, Figure 1D), suggesting that the protein 
undergoes conformational reorganization following its inter-
action with FN. VN is known to interact with the extracellular 
matrix through its collagen- and heparin-binding domains, but 
has not been reported to interact directly with FN in vivo.[1,34] 
Electrostatic interactions, which have been suggested to drive 
FN fibrillogenesis on negatively charged material surfaces,[35] 
might influence the affinity between the two adsorbing species 
and ultimately affect their structural organization. On PEA, FN 
has in fact been proposed to orient at the surface so that its 
hydrophobic and its positively charged domains (e.g., the hep-
arin-binding fragment, FNIII12–14) interact with the slightly neg-
ative charged surface of the polymer (negative net charge in the 
COO group of PEA);[36] this, in turn, prompts the exposure 
of negatively charged domains that would otherwise be buried 
within the compact form of the protein (e.g., III2–3).[35] The 
positively charged heparin-binding domain of VN might then 
interact with the domains exposed by FN, allowing for a con-
formational transition of VN from its folded state, which aligns 
the amino-terminal acidic domains containing the RGD motif 
with the heparin-binding domain, into an extended form.[5b] 
Despite this lack of direct interaction, the behavior observed 
here is in line with reports indicating that, in vivo, the function 
of the protein is influenced and determined by its interactions 
with other species.[1] For example, Peterson et al. showed that 
the interaction of VN with plasminogen activator inhibitor type 
1 during hemostatic processes alters the adhesive functions of 
VN, enhancing its cell/matrix-binding properties as it multim-
erizes and is incorporated into higher order complexes.[37] In 
the artificial but physiological-like FN-based system used in this 
work, VN appears to regulate both the physical properties of 
the matrix (by enhancing the mobility of the protein network) 
and the biological properties (by enhancing its own biological 
activity).
Using a simple cell model with differentiation capability, 
C2C12 myoblasts, we explored whether this apparent regulation 
of the microenvironment properties translated into a control 
of cell response (Figure 8). It is established that cell adhesion 
and differentiation are enhanced on fibrillar FN compared to its 
globular solution conformation;[28,38] in particular, we observed 
that material-driven FN fibrils are able to sustain high myogenic 
differentiation levels[28] and that cell adhesion is improved with 
increased FN density[38] or in the presence of VN.[20] Here, we set 
out to explore short-term cell response to the protein interface 
looking at cell-mediated remodeling following cell attachment; 
the ability of cells to reorganize their surroundings is in fact 
linked to the biocompatibility of the material and its ultimate 
fate in vitro or in vivo.[15] We have previously observed strong 
cell adhesion with traces of reorganization of the adsorbed FN 
by cells in the presence of serum during the culture,[25b,31] this 
is confirmed by the results in this study, as seen in Figure 4, 
fifth column, where good cell spreading (Figure 4E) and FN 
reorganization at the cell edges (Figure 4C) can be seen after 
3 h of culture of C2C12 cells onto fibrillar FN on PEA. However, 
when cells are seeded in serum-free conditions, adhesion is 
impaired, as cells are unable to reorganize the underlying layer 
due to the strong interaction between the FN fibrils and the 
underlying substrate (Figure 4, third column).[39] This strong 
interaction, confirmed via atomic force spectroscopy,[25a] entails 
restricted nanoscale mobility of the protein, with cells ultimately 
trying degrading the interface via proteolysis.[25a,40] The pres-
ence of VN integrated in the FN fibrils at the material interface 
leads to a recovery from this effect, as cells appear to be able to 
spread (Figure 4E) and reorganize the adsorbed FN (Figure 4C, 
first column). It has been, in fact, reported that engagement 
of VN receptors might initiate assembly of FN by cells,[7] and 
this might be in line with our observations. On the other hand, 
blocking the availability of VN to cells using a monoclonal anti-
body does not ablate cell response (Figure 4, second column), 
suggesting that the increased mobility granted by the VN mole-
cules in the FN matrix is sufficient to allow for a better cell 
attachment and FN reorganization in serum-free conditions. 
This role of VN as a micromanager of the fibrillar microenvi-
ronment is confirmed by the mixed cell response when VN is 
added simply as a soluble factor during the culture (Figure 4, 
fourth column); cells mostly fail to reorganize the underlying 
protein interface and adopt a shrunk morphology, as the phys-
ical properties of the microenvironment are unchanged and 
the engagement of VN receptors is less efficient. VN is, in fact, 
largely unreactive in aqueous phase.[1]
Myogenic differentiation assays interestingly revealed a 
nonmonotonic cell response to these FN/VN interfaces: differ-
entiation levels are higher on pure coatings and diminish for 
ratios of adsorbed VN to total adsorbed protein (XVN) up to 60% 
(Figures 5 and 8B). The high differentiation degree of C2C12 
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cells on fibrillar fibronectin has been previously reported, and 
correlated to the ability of cells to bind to unfolded FN and exert 
forces;[28] besides, the fundamental role of fibronectin in myo-
genesis has been further established.[41] On the other hand, the 
high level of differentiation on VN is likely linked to an earlier 
onset of cell fusion, as shown by observing cell differentiation 
over time (Figure 6). The engagement of VN receptors favors 
the organization of cells into clusters at earlier time points, 
leading to higher levels of cell fusion and ultimately high dif-
ferentiation. Additionally, VN has been previously reported to 
be able to sustain the adhesion, growth, and efficient myogenic 
differentiation of C2C12 cells.[42] We postulate that the observed 
nonmonotonic response on the mixed coatings stems from the 
opposing effects on myogenic differentiation of the physical 
and biological changes in the biointerface properties granted 
by the integration of VN. The increase in mobility due to the 
plasticizing effect of VN appears to be dominant for VN ratios 
at the interface lower than 60%, when it leads to a decrease 
in cell differentiation levels. Indeed, we have previously 
observed a contractility-dependent response of C2C12 cells to 
an increase in interfacial mobility, resulting in a decrease of 
differentiation.[25b] On the other hand, when the amount of VN 
is significant, the dominant factor controlling differentiation is 
the engagement of the VN receptors, allowing the increase of 
cell fusion to grant a higher differentiation degree. Preventing 
the engagement of cell receptors with the RGD sequence on 
either FN or VN confirms the role of each of the two proteins 
making up the interface. Indeed, blocking VN ablates the con-
tribution of VN receptors engagement to cell fusion and dif-
ferentiation, further reducing myogenic differentiation as the 
increased mobility of the FN interface remains the only factor 
playing a role in cell response. Blocking access to the central 
integrin-binding domain on FN, on the other hand, has a lesser 
effect, with the enhanced engagement of VN receptors allowing 
a slight increase of the fusion and differentiation levels.
4. Conclusion
This work aims at augmenting the complexity of an artificial 
FN fibrillar microenvironment by using a multifunctional 
matricellular glycoprotein and main adhesive component of 
serum, VN. Similarly to VN activity in vivo, VN appears to 
micromanage the local properties of the microenvironment, 
altering both its physical and biological features. As a result, 
these substrate-induced protein matrices have the potential to 
fine-tune cell behavior, with VN micromanaging short-term cell 
response to the protein interface and higher order cellular func-
tions such as differentiation. In perspective, this system can be 
further employed to target cell response in tissue regeneration 
applications involving the use of bound GFs; VN has in fact the 
ability to bind several GFs, allowing the modulation of syner-
gistic signaling events prompted by the FN fibrils.
5. Experimental Section
Preparation of PEA Films and Protein Adsorption: Thin films of PEA 
were obtained by spin coating a 4% w/v solution of bulk PEA in toluene 
at 2000 rpm for 30 s onto 12 mm glass coverslips (VWR) cleaned via 
sonication in ethanol; samples were dried in vacuo at 60 °C for 2 h 
before further characterization and use. The bulk PEA was previously 
polymerized through radical polymerization of ethyl acrylate (Sigma-
Aldrich) with 1% w/w benzoin (Sigma-Aldrich) as a photoinitiator 
for 12 h.
Samples were sterilized via UV for 20 min and coated with the 
proteins at a total concentration of 10 µg mL−1 in Dulbecco’s phosphate-
buffered saline containing calcium and magnesium (DPBS, Gibco) for 
1 h at room temperature (RT). After coating, samples were rinsed once 
with DPBS prior to use. FN and VN, both from human plasma (Sigma-
Aldrich), were used for the coatings in different FN/VN weight (molar) 
ratios: 100/0 (100/0), 70/30 (28/72), 50/50 (15/85), 30/70 (7/93), and 
0/100 (0/100). Pure protein coatings were also performed at different 
concentrations (10, 7, 5, and 3 µg mL−1), and consecutive FN + VN 
and VN + FN coatings were performed using 5 µg mL−1 solutions of 
the pure protein; samples were rinsed with DPBS after each coating. 
For observation via atomic force microscopy (AFM), samples were also 
rinsed with Milli-Q water before drying gently with a nitrogen flow.
Quantification of Protein Adsorption: The amount of adsorbed FN 
or VN was measured via depletion of the protein from the coating 
solution. Specifically, the amount of FN remaining in the supernatant 
after adsorption for 1 h was quantified via western blot as explained 
in Rico et al.[43] The amount of VN remaining in the supernatant 
after 1 h adsorption was quantified via enzyme-linked immunosorbent 
assay (ELISA) (Human Vitronectin ELISA kit, ThermoFisher Scientific), 
following manufacturer instructions; the amount of protein in the 
coating solutions was confirmed via bicinchoninic acid assay (Micro 
BCA, ThermoFisher Scientific).
Availability of FN or VN for cell binding through the RGD domain was 
measured via a direct ELISA with monoclonal antibodies at RT. Samples 
were incubated with the primary antibody at 0.1 µg mL−1 in 1% w/v 
BSA/DPBS for 1 h after blocking for 30 min with 1% w/v bovine serum 
albumin (BSA)/DPBS; mouse HFN7.1 (DSHB) monoclonal antibody 
was used to detect the central integrin-binding domain on human FN, 
while mouse mab1945 (Millipore) was used for human VN. Samples 
were then washed twice in 0.5% v/v Tween20/DPBS, and incubated with 
a goat antimouse HRP-conjugated secondary antibody (Invitrogen) at 
0.1 µg mL−1 in 1% w/v BSA/DPBS for 1 h. After washing the samples 
twice with 0.5% v/v Tween20/DPBS and transferring them to a clean 
24-well multiwell plate, they were incubated with an horseradish 
peroxidase (HRP)-substrate solution (R&D Systems) for 20 min; the 
reaction was stopped using a stop solution (R&D Systems) before 
transferring the solution to a 96-well multiwell plate. Absorbance was 
read in a Tecan plate reader at 450 nm with wavelength correction at 
570 nm; three readings were performed for each sample.
Atomic Force Microscopy: Phase and height images were obtained 
for protein-coated PEA surfaces using AFM in AC mode (Nanowizard 
3 Bioscience AFM, JPK). A pyramidal silicon nitride tip, with a cantilever 
spring constant of ≈3 N m−1 and a resonance frequency of ≈75 kHz 
(MPP-21120, Bruker), was used.
The phase images were processed using the JPK Data Processing 
software (version 5.0.84) and analyzed using the ImageJ software 
(1.47v). The fractal dimension was determined using the ImageJ fractal 
box count analysis tool, using box sizes of 2, 3, 4, 6, 8, 12, 16, 32, and 
64 pixels onto 1 × 1 µm2 images after conversion to 8 bit grayscale, 
followed by thresholding and binarization. The junctions to end points 
ratios, and the average and maximum branch lengths were calculated 
by using the Analyze Skeleton ImageJ plug-in on the skeletonized binary 
images.
For immunogold labeling and imaging of available VN molecules, 
protein-coated samples were fixed in 4% v/v formaldehyde in DPBS 
for 30 min, followed by incubation with mab1945 at 2.5 µg mL−1 in 
DPBS for 1 h. After washing thrice with 0.5% v/v Tween20/DPBS for 
5 min with agitation, samples were incubated with a goat antimouse 
secondary antibody tagged with a 15 nm gold nanoparticle (Aurion) 
at a 1:20 dilution in DPBS for 1 h. Samples were then washed thrice 
with 0.5% v/v Tween20/DPBS for 5 min with agitation, washed twice 
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for 5 min in DPBS with agitation, fixed with 4% v/v formaldehyde in 
DPBS for 5 min, washed twice with Milli-Q water for 5 min, and 
finally gently dried with nitrogen flow before imaging in AC mode as 
previously detailed. Height images were thresholded to identify the gold 
nanoparticles using the Gwyddion software (version 2.36) with a 60% 
height threshold. Thresholded height images were then superimposed 
to the corresponding phase signal to identify the location of the gold 
nanoparticles within the protein coating.
Cell Culture: C2C12 mouse myoblast cells were obtained from ATTC 
and passaged according to standard procedures using Dulbecco’s 
Modified Eagle’s Medium (DMEM, Gibco) with 4.5 g L−1 of d-glucose 
and l-glutamine supplemented with 1% penicillin/streptomycin (P/S, 
Gibco), and 20% fetal bovine serum (FBS, Gibco) as growth medium. 
All cells used for experiments were of passage below 8.
For FN reorganization experiments cells were seeded on the protein-
coated surfaces (50/50 mixed coatings and pure 5 µg mL−1 FN coatings) 
at a density of 5000 cells cm−2 in serum-free medium. VN availability 
on the mixed coating was blocked by incubation of the protein coating 
with the mab1945 antibody at 25 µg mL−1 in DPBS (1:1 molar ratio 
to VN)[22] followed by rinsing thrice with DPBS prior to cell culture. 
Controls included cells seeded onto pure FN coatings in the presence 
of 5 µg mL−1 of VN in the culture medium or in the presence of 2.5% 
FBS (which contains VN at roughly the same concentration). After 3 h, 
samples were fixed with 4% v/v formaldehyde in DPBS for 30 min at 
4 °C and stained for actin, nuclei, and FN. Specifically, samples were 
permeabilized using a 10.3% w/v sucrose, 0.292% w/v NaCl, 0.06% w/v 
MgCl2, 0.476% w/v 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
(HEPES), 0.5% v/v Triton X-100 solution in Milli-Q water (pH 7.2) at RT 
for 5 min, blocked with 1% w/v BSA/DPBS for 30 min, and incubated 
with a rabbit polyclonal antibody against human FN (Sigma) diluted 
1:400 in 1% w/v BSA/DPBS for 1 h. After washing twice with 0.5% v/v 
Tween20/DPBS, samples were incubated with a 1:200 goat antirabbit 
Cy3-conjugated secondary antibody (Jackson ImmunoResearch) and 
a 1:100 BODIPY FL phallacidin (to stain the actin cytoskeleton; Life 
Technologies) solution in 1% w/v BSA/DPBS. Samples were finally 
mounted in a Vectashield mounting medium containing 4′,6-diamino-
2-phenylindole (DAPI, Vector Laboratories) to stain the nuclei and 
observed using an AxioObserver Z1 inverted fluorescence microscope 
(Zeiss). Cell size was measured from the actin cytoskeleton images 
using ImageJ; experiments were performed in triplicate, and at least 
50 cells were measured per each condition.
For myogenic differentiation experiments, cells were seeded 
on the protein-coated surfaces at a density of 20 000 cells cm−2 in 
differentiation medium (DMEM + 1% P/S + 1% insulin-transferrin-
selenium-ethanolamine, ITS-X, Life Technologies) and cultured for 
4 d, with the medium being replaced 3 h and 2 d after seeding. FN or 
VN availability was blocked by incubation of the protein coating with 
HFN7.1 (7.3 µg mL−1, 1:1 molar ratio to FN) or mab1945 (25 µg mL−1, 
1:1 molar ratio to VN)[22] antibody, respectively, followed by rinsing 
thrice with DPBS prior to cell culture. After 4 d of culture, cells were 
fixed and permeabilized with a 20:2:1 70% ethanol/37% formaldehyde/
acetic acid solution for 10 min at 4 °C. Myogenic differentiation was 
then evaluated by staining for sarcomeric myosin. Samples were 
incubated for 1 h in a 5% goat serum/DPBS blocking buffer, followed 
by washing thrice with DPBS and incubating 1 h with MF-20 mouse 
antibody (DSHB) at 37 °C. After washing thrice in DPBS and blocking 
10 min with blocking buffer, samples were incubated with antimouse 
Cy3-conjugated secondary antibody (Jackson ImmunoResearch) for 
1 h, washed and finally mounted using Vectashield containing DAPI. 
Samples were observed using an AxioObserver Z1 inverted fluorescence 
microscope. The degree of myogenic differentiation was determined as 
the percentage of cells positive for sarcomeric myosin using the CellC 
cell counting software;[44] cell density was determined by counting the 
total number of nuclei using the same software; experiments were 
performed in triplicate and at least nine 1565 × 1568 µm2 images 
were analyzed per each condition. The perimeter-to-area ratio of the 
myotubes, used as an indicator of the level of cell fusion, was calculated 
using ImageJ by outlining the thresholded binarized images of the 
sarcomeric myosin staining; at least five 1565 × 1568 µm2 images 
were analyzed per each condition. In the case of the experiments 
to assess cell differentiation over time, samples were fixed after 3 h, 
1 d, 2 d, 3 d, and 4 d of culture using 4% v/v formaldehyde in DPBS 
for 30 min at 4 °C. Then, samples were permeabilized using a 10.3% 
w/v sucrose, 0.292% w/v NaCl, 0.06% w/v MgCl2, 0.476% w/v HEPES, 
0.5% v/v Triton X-100 solution in Milli-Q water (pH 7.2) at RT for 5 min, 
blocked with 1% w/v BSA/DPBS for 30 min and incubated with a 1:100 
BODIPY FL phallacidin solution in 1% w/v BSA/DPBS to stain the actin 
cytoskeleton. Samples were finally mounted in a Vectashield mounting 
medium containing DAPI to stain the nuclei and observed using an 
AxioObserver Z1 inverted fluorescence microscope. Cell density was 
measured using CellC to count the total number of cell nuclei per 
image, while the percentage of confluence was determined from the 
thresholded binarized actin staining images using ImageJ; experiments 
were performed in triplicate and at least six 1565 × 1568 µm2 images 
were analyzed per each condition.
Statistical Analysis: Experiments were performed at least in triplicate, 
and the values of the measurements are reported as the average of the 
samples, with the variability expressed in terms of standard deviation. 
Statistically significant differences were determined by one-way analysis 
of variance (ANOVA), with p < 0.05.
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